Cargando…
Corrigendum: The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study
Autores principales: | Na, Soo Jin, Youn, Jong-Chan, Lee, Hye Sun, Jeon, Soyoung, Lee, Hae-Young, Cho, Hyun-Jai, Choi, Jin-Oh, Jeon, Eun-Seok, Lee, Sang Eun, Kim, Min-Seok, Kim, Jae-Joong, Hwang, Kyung-Kuk, Cho, Myeong-Chan, Chae, Shung Chull, Kang, Seok-Min, Choi, Dong-Ju, Yoo, Byung-Su, Kim, Kye Hun, Oh, Byung-Hee, Baek, Sang Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037060/ https://www.ncbi.nlm.nih.gov/pubmed/35479279 http://dx.doi.org/10.3389/fcvm.2022.888829 |
Ejemplares similares
-
The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study
por: Na, Soo Jin, et al.
Publicado: (2022) -
Prognostic Impact and Predictors of New-Onset Atrial Fibrillation in Heart Failure
por: Choi, Hyo-In, et al.
Publicado: (2022) -
Coronary artery bypass graft versus percutaneous coronary intervention in acute heart failure
por: Lee, Sang Eun, et al.
Publicado: (2020) -
Management and Prognosis of Heart Failure in Octogenarians: Final Report from the KorAHF Registry
por: Oh, Gyu Chul, et al.
Publicado: (2020) -
Real‐world eligibility for vericiguat in decompensated heart failure with reduced ejection fraction
por: Oh, Jaewon, et al.
Publicado: (2022)